![]() |
|
|||
|
The U.S. Food and Drug Administration has approved Amgen Inc's bone drug denosumab as a treatment for reducing fractures and other bone problems in cancer patients with solid tumors, a spokeswoman for the agency said on Thursday.
|
| Thread Tools | |
| Display Modes | |
|
|